1. Engineering Gac/Rsm Signaling Cascade for Optogenetic Induction of the Pathogenicity Switch in Pseudomonas aeruginosa .
- Author
-
Cheng X, Pu L, Fu S, Xia A, Huang S, Ni L, Xing X, Yang S, and Jin F
- Subjects
- Animals, Bacterial Proteins genetics, Host-Pathogen Interactions genetics, Light, Microorganisms, Genetically-Modified, Protein Engineering methods, Protein Kinases genetics, Pseudomonas aeruginosa genetics, Signal Transduction radiation effects, Transcription Factors genetics, Virulence genetics, Virulence radiation effects, Virulence Factors genetics, Bacterial Proteins metabolism, Caenorhabditis elegans microbiology, Optogenetics methods, Protein Kinases metabolism, Pseudomonas aeruginosa metabolism, Pseudomonas aeruginosa pathogenicity, Signal Transduction genetics, Transcription Factors metabolism, Virulence Factors metabolism
- Abstract
Bacterial pathogens operate by tightly controlling the pathogenicity to facilitate invasion and survival in host. While small molecule inducers can be designed to modulate pathogenicity to perform studies of pathogen-host interaction, these approaches, due to the diffusion property of chemicals, may have unintended, or pleiotropic effects that can impose limitations on their use. By contrast, light provides superior spatial and temporal resolution. Here, using optogenetics we reengineered GacS of the opportunistic pathogen Pseudomonas aeruginosa , signal transduction protein of the global regulatory Gac/Rsm cascade which is of central importance for the regulation of infection factors. The resultant protein (termed YGS24) displayed significant light-dependent activity of GacS kinases in Pseudomonas aeruginosa . When introduced in the Caenorhabditis elegans host systems, YGS24 stimulated the pathogenicity of the Pseudomonas aeruginosa strain PAO1 in a brain-heart infusion and of another strain, PA14, in slow killing media progressively upon blue-light exposure. This optogenetic system provides an accessible way to spatiotemporally control bacterial pathogenicity in defined hosts, even specific tissues, to develop new pathogenesis systems, which may in turn expedite development of innovative therapeutics.
- Published
- 2021
- Full Text
- View/download PDF